Literature DB >> 27605878

Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Daniel Åkerberg1, Daniel Ansari1, Roland Andersson1.   

Abstract

Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only potential cure. Yet, even among patients that undergo tumor resection, recurrence rates are high and long-term survival is scarce. Various tumor-related factors have been identified as predictors of survival after potentially curative resection. These factors include tumor size, lymph node disease, tumor grade, vascular invasion, perineural invasion and surgical resection margin. This article will re-evaluate the importance of these factors based on recent publications on the topic, with potential implications for treatment and outcome in patients with pancreatic cancer.

Entities:  

Keywords:  Pancreatic cancer; Prognostic factors; Survival

Mesh:

Year:  2016        PMID: 27605878      PMCID: PMC4968124          DOI: 10.3748/wjg.v22.i28.6424

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  93 in total

Review 1.  Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

Authors:  P Bachellier; H Nakano; P D Oussoultzoglou; J C Weber; K Boudjema; P D Wolf; D Jaeck
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

2.  Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Yoshio Yuasa; Taijiro Sueda
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

4.  Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.

Authors:  Ippei Matsumoto; Yoshiaki Murakami; Makoto Shinzeki; Sadaki Asari; Tadahiro Goto; Masaji Tani; Fuyuhiko Motoi; Kenichiro Uemura; Masayuki Sho; Sohei Satoi; Goro Honda; Hiroki Yamaue; Michiaki Unno; Takahiro Akahori; A-Hon Kwon; Masanao Kurata; Tetsuo Ajiki; Takumi Fukumoto; Yonson Ku
Journal:  Pancreatology       Date:  2015-10-03       Impact factor: 3.996

5.  An Increased Number of Perineural Invasions Is Independently Associated With Poor Survival of Patients With Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Naru Kondo; Yoshiaki Murakami; Kenichiro Uemura; Yasushi Hashimoto; Naoya Nakagawa; Hayato Sasaki; Taijiro Sueda
Journal:  Pancreas       Date:  2015-11       Impact factor: 3.327

6.  Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Tomoo Kosuge
Journal:  Ann Surg Oncol       Date:  2006-12       Impact factor: 5.344

7.  Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer.

Authors:  Charles W Kimbrough; Charles R St Hill; Robert C G Martin; Kelly M McMasters; Charles R Scoggins
Journal:  J Surg Oncol       Date:  2013-02-28       Impact factor: 3.454

8.  Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

Authors:  Ioannis T Konstantinidis; Andrew L Warshaw; Jill N Allen; Lawrence S Blaszkowsky; Carlos Fernandez-Del Castillo; Vikram Deshpande; Theodore S Hong; Eunice L Kwak; Gregory Y Lauwers; David P Ryan; Jennifer A Wargo; Keith D Lillemoe; Cristina R Ferrone
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

9.  Prognostic factors after resection of pancreatic cancer.

Authors:  Michio Ueda; Itaru Endo; Masayuki Nakashima; Yuta Minami; Kazuhisa Takeda; Kenichi Matsuo; Yasuhiko Nagano; Kuniya Tanaka; Yasushi Ichikawa; Shinji Togo; Chikara Kunisaki; Hiroshi Shimada
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

10.  Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases.

Authors:  G Klöppel; G Lingenthal; M von Bülow; H F Kern
Journal:  Histopathology       Date:  1985-08       Impact factor: 5.087

View more
  8 in total

1.  Natural History and Treatment Trends in Pancreatic Cancer Subtypes.

Authors:  Courtney J Pokrzywa; Daniel E Abbott; Kristina A Matkowskyj; Sean M Ronnekleiv-Kelly; Emily R Winslow; Sharon M Weber; Alexander V Fisher
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

2.  Surgical Margin Status of Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Radical Intent: Risk Factors for the Survival Impact of Positive Margins.

Authors:  Chun-Chi Lai; Shang-Yu Wang; Chien-Hung Liao; Jun-Te Hsu; Kun-Chun Chiang; Ta-Sen Yeh; Tsann-Long Hwang; Chun-Nan Yeh
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

3.  A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?

Authors:  Toru Nakamura; Toshimichi Asano; Keisuke Okamura; Takahiro Tsuchikawa; Soichi Murakami; Yo Kurashima; Yuma Ebihara; Takehiro Noji; Yoshitsugu Nakanishi; Kimitaka Tanaka; Toshiaki Shichinohe; Satoshi Hirano
Journal:  J Gastrointest Surg       Date:  2018-09-21       Impact factor: 3.452

4.  Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.

Authors:  Chihiro Sakugawa; Yukihiro Haruyama; Hiroyuki Tanaka; Tsuyoshi Fukushima; Makiko Kawaguchi; Hiroaki Kataoka
Journal:  BMC Res Notes       Date:  2017-12-04

5.  Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.

Authors:  Yan-Hui Yang; Jiang-Bo Liu; Yang Gui; Liang-Liang Lei; Shui-Jun Zhang
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

6.  Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.

Authors:  Na Chang; Lingling Cui; Yahong Luo; Zhihui Chang; Bing Yu; Zhaoyu Liu
Journal:  Quant Imaging Med Surg       Date:  2020-03

7.  The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.

Authors:  Elisabeth S Gruber; Gerd Jomrich; Alexandra Kaider; Michael Gnant; Klaus Sahora; Martin Schindl
Journal:  Ann Surg Oncol       Date:  2020-01-03       Impact factor: 5.344

8.  Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.

Authors:  Elisabeth S Gruber; Gerd Jomrich; Dietmar Tamandl; Michael Gnant; Martin Schindl; Klaus Sahora
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.